Home › Entities › doctoral_thesis › Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)

2018 doctoral thesis by VJ Jackson-Patel at University of Auckland
Place doctoral_thesis Q112936777
Press Enter · cited answer in seconds

Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Summary

Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN) is a doctoral thesis[1].

Key Facts

  • Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN) authored Victoria Jackson-Patel[2].
  • Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)'s instance of is recorded as doctoral thesis[3].
  • Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)'s publisher is recorded as ResearchSpace@Auckland[4].
  • Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)'s copyright license is recorded as Creative Commons Attribution-NonCommercial-ShareAlike 3.0 New Zealand[5].
  • Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)'s country of origin is recorded as New Zealand[6].
  • Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)'s publication date is recorded as +2018-00-00T00:00:00Z[7].
  • Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)'s main subject is recorded as biomedical sciences[8].
  • Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)'s work available at URL is recorded as https://researchspace.auckland.ac.nz/handle/2292/43476[9].
  • Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)'s Handle ID is recorded as 2292/43476[10].
  • Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)'s title is recorded as Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)[11].
  • Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)'s copyright holder is recorded as Victoria Jackson-Patel[12].
  • Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)'s thesis submitted to is recorded as University of Auckland[13].
  • Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)'s on focus list of Wikimedia project is recorded as NZThesisProject[14].
  • Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)'s copyright status is recorded as copyrighted[15].
  • Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)'s online access status is recorded as open access[16].
  • Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)'s thesis committee member is recorded as Adam Patterson[17].
  • Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)'s thesis committee member is recorded as Jeff Smaill[18].
  • Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)'s thesis committee member is recorded as Chris P. Guise[19].
  • Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)'s thesis committee member is recorded as Kevin O Hicks[20].

Body

Designation and Status

Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)'s instance of is recorded as doctoral thesis[3].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [3] ↑ . wikidata.org.
  2. [2] ↑ . hdl.handle.net. hdl.handle.net. Provenance: wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.
  17. [18] ↑ . wikidata.org.
  18. [19] ↑ . wikidata.org.
  19. [20] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN). Retrieved May 3, 2026, from https://4ort.xyz/entity/inhibiting-the-epidermal-growth-factor-receptor-egfr-to-improve-clinical-outcomes-for-patients-with-squamous-cell-carcinoma-of-the-head-and-neck-scchn-
MLA “Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN).” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/inhibiting-the-epidermal-growth-factor-receptor-egfr-to-improve-clinical-outcomes-for-patients-with-squamous-cell-carcinoma-of-the-head-and-neck-scchn-.
BibTeX @misc{4ortxyz_inhibiting-the-epidermal-growth-factor-receptor-egfr-to-improve-clinical-outcomes-for-patients-with-squamous-cell-carcinoma-of-the-head-and-neck-scchn-_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)}}, year = {2026}, url = {https://4ort.xyz/entity/inhibiting-the-epidermal-growth-factor-receptor-egfr-to-improve-clinical-outcomes-for-patients-with-squamous-cell-carcinoma-of-the-head-and-neck-scchn-}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN) — https://4ort.xyz/entity/inhibiting-the-epidermal-growth-factor-receptor-egfr-to-improve-clinical-outcomes-for-patients-with-squamous-cell-carcinoma-of-the-head-and-neck-scchn- (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/inhibiting-the-epidermal-growth-factor-receptor-egfr-to-improve-clinical-outcomes-for-patients-with-squamous-cell-carcinoma-of-the-head-and-neck-scchn- · Last refreshed: